IL161449A0 - Process for resolution of tamsulosin - Google Patents

Process for resolution of tamsulosin

Info

Publication number
IL161449A0
IL161449A0 IL16144902A IL16144902A IL161449A0 IL 161449 A0 IL161449 A0 IL 161449A0 IL 16144902 A IL16144902 A IL 16144902A IL 16144902 A IL16144902 A IL 16144902A IL 161449 A0 IL161449 A0 IL 161449A0
Authority
IL
Israel
Prior art keywords
tamsulosin
resolution
Prior art date
Application number
IL16144902A
Other languages
English (en)
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of IL161449A0 publication Critical patent/IL161449A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42Separation; Purification; Stabilisation; Use of additives
    • C07C303/44Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16144902A 2001-10-31 2002-10-15 Process for resolution of tamsulosin IL161449A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33081701P 2001-10-31 2001-10-31
US10/208,009 US6835853B2 (en) 2001-10-31 2002-07-31 Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
PCT/NL2002/000657 WO2003037850A1 (en) 2001-10-31 2002-10-15 Process for resolution of tamsulosin

Publications (1)

Publication Number Publication Date
IL161449A0 true IL161449A0 (en) 2004-09-27

Family

ID=26902810

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16144902A IL161449A0 (en) 2001-10-31 2002-10-15 Process for resolution of tamsulosin
IL16149002A IL161490A0 (en) 2001-10-31 2002-10-17 Racemic tamsulosin free base and methods of making the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL16149002A IL161490A0 (en) 2001-10-31 2002-10-17 Racemic tamsulosin free base and methods of making the same

Country Status (17)

Country Link
US (2) US6835853B2 (zh)
EP (2) EP1444198A1 (zh)
CN (2) CN100343227C (zh)
AT (2) ATE417822T1 (zh)
AU (2) AU2002330774B9 (zh)
CA (2) CA2464648C (zh)
CH (3) CH697164A5 (zh)
CZ (2) CZ13580U1 (zh)
DE (3) DE60230438D1 (zh)
DK (2) DK200200339U3 (zh)
FI (2) FI5816U1 (zh)
FR (2) FR2832146B1 (zh)
IL (2) IL161449A0 (zh)
IS (2) IS6603A (zh)
NL (2) NL1021671C2 (zh)
NO (1) NO20042256L (zh)
WO (2) WO2003037850A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2200699B1 (es) * 2002-07-12 2005-10-01 Ragactives, S.L Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.
USH2154H1 (en) * 2003-10-08 2006-04-04 Farmak, A.S. Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
SI21656A (sl) * 2003-12-29 2005-06-30 LEK farmacevtska družba d.d. Priprava (R)-5-(2-(2-(2-etoksifenoksi) etilamino)-1-propil)-2-metoksibenzensulfonamida hidroklorida z visoko kemijsko čistoto
SI21702A (en) * 2004-01-29 2005-08-31 Lek Farmacevtska Druzba Dd Preparation of amorphous form of tamsulosin
WO2005089511A2 (en) * 2004-03-19 2005-09-29 Transform Pharmaceuticals, Inc. Novel pharmaceutical forms, and methods of making and using the same
CN100545148C (zh) 2004-08-16 2009-09-30 神隆新加坡私人有限公司 一种抗良性前列腺肥大药物坦索罗辛之合成方法
US7238839B2 (en) 2004-10-07 2007-07-03 Divi's Laboratories Limited Process for the resolution of racemic (R,S) -5-(2-(2-(2- ethoxyphenoxy) ethylamino)Propyl)-2-methoxybenzene sulfonamide (tamsulosin), its novel R and S isomers and their salts and processes for their preparation
PT103216B (pt) 2004-12-06 2010-05-19 Hovione Farmaciencia S A Preparação de tamsulosin
WO2006117662A2 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Polymorphic forms of (r)-(-)-tamsulosin
US20090137844A1 (en) * 2005-06-15 2009-05-28 Fermion Oy Crystallization process
WO2007131804A1 (en) 2006-05-17 2007-11-22 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
US20080312328A1 (en) * 2007-06-14 2008-12-18 Protia, Llc Deuterium-enriched tamsulosin
DE102008002409A1 (de) * 2008-06-13 2009-12-17 Evonik Goldschmidt Gmbh Enzymatische Synthese von Sphingolipiden
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
EP2338876A1 (en) 2009-12-22 2011-06-29 LEK Pharmaceuticals d.d. Tamsulosin adipate for pharmaceutical use
KR101525493B1 (ko) * 2013-01-02 2015-06-03 보령제약 주식회사 고순도 탐술로신 또는 이의 염 제조방법
CN104926699B (zh) * 2015-07-02 2018-09-25 成都丽凯手性技术有限公司 一种高光学纯度盐酸坦索罗辛的制备方法
CN106631918B (zh) * 2016-10-13 2018-07-13 深圳万和制药有限公司 拆分坦索罗辛对映异构体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH383998A (de) * 1959-08-05 1964-11-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
US3261829A (en) * 1964-08-12 1966-07-19 Searle & Co Spiro(steroidal-6,3'-1-pyrazolines) and process
CA1147342A (en) 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
JPS56110665A (en) 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
JPH066565B2 (ja) 1986-07-21 1994-01-26 山之内製薬株式会社 光学活性なベンゼンスルホンアミド誘導体の製造法
DE59401361D1 (de) * 1993-02-23 1997-02-06 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Also Published As

Publication number Publication date
DK200200338U1 (da) 2003-01-31
WO2003037851A1 (en) 2003-05-08
CN1578761A (zh) 2005-02-09
NO20042256L (no) 2004-07-28
NL1021671C2 (nl) 2003-05-15
CA2464917A1 (en) 2003-05-08
FIU20020420U0 (fi) 2002-10-23
AU2002330776B2 (en) 2009-03-12
WO2003037850A1 (en) 2003-05-08
FI5957U1 (fi) 2003-09-30
US6965051B2 (en) 2005-11-15
CN1578762A (zh) 2005-02-09
ATE417822T1 (de) 2009-01-15
US20050096394A1 (en) 2005-05-05
IL161490A0 (en) 2004-09-27
DE60230438D1 (de) 2009-01-29
EP1444199A1 (en) 2004-08-11
CH697164A5 (de) 2008-05-30
FR2832146A1 (fr) 2003-05-16
DK200200339U1 (da) 2003-01-31
CZ13392U1 (cs) 2003-06-24
US6835853B2 (en) 2004-12-28
CZ13580U1 (cs) 2003-08-18
CH697034A5 (de) 2008-03-31
DE20216779U1 (de) 2003-09-04
DE20216835U1 (de) 2003-09-25
EP1444198A1 (en) 2004-08-11
FIU20020421U0 (fi) 2002-10-23
NL1021678C2 (nl) 2003-05-15
IS6603A (is) 2003-05-02
IS6602A (is) 2003-05-02
CN100579958C (zh) 2010-01-13
EP1444199B1 (en) 2008-12-17
FR2832146B1 (fr) 2006-05-26
US20030109752A1 (en) 2003-06-12
AU2002330774B9 (en) 2010-01-07
CH696665A5 (de) 2007-09-14
CA2464648C (en) 2009-07-14
FR2832147A1 (fr) 2003-05-16
FI5816U1 (fi) 2003-06-06
CN100343227C (zh) 2007-10-17
FR2832147B1 (fr) 2006-06-02
CA2464648A1 (en) 2003-05-08
DK200200338U3 (da) 2003-07-11
CA2464917C (en) 2009-06-02
DK200200339U3 (da) 2003-06-13
AT6687U1 (de) 2004-02-25
AU2002330774B2 (en) 2009-06-04

Similar Documents

Publication Publication Date Title
EP1427743A4 (en) SYNTHESIS OF PYRAZOLOPYRIMIDINES
IL146389A0 (en) Process for the preparation of dronedarone
IL161449A0 (en) Process for resolution of tamsulosin
HUP0402027A3 (en) Process for the preparation of a xantophyll
PL368600A1 (en) Process for the preparation of tolterodine
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
EP1391518A4 (en) PROCESS FOR PEPTIDE MANUFACTURE
SI1423360T1 (sl) Postopek za izdelavo cilastatina
IL150600A0 (en) Process for the preparation of peptides
HUP0201837A3 (en) Process for preparation n-carboxy-anhydrides
PL370705A1 (en) Process for the preparation of imipenem
EP1547993A4 (en) PROCESS FOR PREPARING SPIROFLUORENOLS
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
AU8824201A (en) Process for the preparation of dinapsoline
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
SG108831A1 (en) Process for preventing formation of scale
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
IL164788A0 (en) Process for the preparation of 3-isochromanone
HUP0401165A3 (en) Process for the preparation of 5-formylphtalide
HRP20010190B1 (en) Process for the preparation of alpha-arbutine
GB0113667D0 (en) Process for the preparation of endo-5-norbornene-2-ol